| Code | Product | Strength | Indication | GMP | Registration |
|---|---|---|---|---|---|
| UB947 | Doxazosin Mesylate Tablet | 2mg | Hypertension; Benign prostatic hyperplasia | CN - NMPA | China |
| UB945 | Terazosin Hydrochloride Tablet | 2mg | Hypertension; Benign prostatic hyperplasia urinary symptoms | CN - NMPA | China |
| UB932 | Compound Dihydralazine Sulfate Tablet | 12.5mg | Stage I hypertension; Stage II hypertension; Renovascular hypertension; Renal hypertension | CN - NMPA | China |
| UB927 | Hydrochlorothiazide Tablet | 25 mg | Edema; Hypertension; Diabetes insipidus; Nephrolithiasis | CN - NMPA | China |
| UB918 | Finerenone Tablet | 10mg, 20mg | Chronic kidney disease; Proteinuria; Type 2 diabetes mellitus | CN - NMPA | China |
| UB866 | Mycophenolic acid DR Tablets | 180mg, 360mg | Renal transplant rejection prophylaxis | US - FDA | United States |
| UB819 | Neostigmine Methylsulfate Injection | 2ml:1mg | Myasthenia gravis; Postoperative paralytic ileus; Urinary retention; Reversal of non-depolarizing neuromuscular blocking agents | CN - NMPA | China |
| UB811 | Urapidil Tablet | / | Essential hypertension; Micturition disorder; Benign prostatic hyperplasia | CN - NMPA | China |
| UB792 | Finasteride Tablets | 5mg | Benign prostatic hyperplasia; Prostatic enlargement; Acute urinary retention; Lower urinary tract symptoms | PIC/S; US - FDA | China |
| UB743 | Compound α-Ketoacid Tablets | 0.63 g * 48, 60, 96, 100 tablets/carton | Chronic kidney disease | CN - NMPA | China |
| UB717 | Bumetanide tablet | 0.5mg 1mg 2mg | Edema; Heart failure; Liver cirrhosis; Renal disease; Hypertension | US - FDA; UK - MHRA | United States |
| UB646 | Tolvaptan tablet | / | Hypervolaemic hyponatraemia; Euvolaemic hyponatraemia; Fluid retention | CN - NMPA; US - FDA; PH - FDA | China |
| UB596 | Tobramycin Sulfate for Injection | 80mg | Neonatal sepsis; Central nervous system infection; Meningitis; Genitourinary tract infection; Lower respiratory tract infection; Biliary tract infection; Intra-abdominal infection; Peritonitis; Osteomyelitis; Burn; Skin infection; Soft tissue infection; Otitis media; Sinusitis; Encephalitis; Ventriculitis | CN - NMPA | China |
| UB594 | Bumetanide Injection | 1ml:0.5mg; 4ml:2mg | Cardiac failure congestive; Cirrhosis; Pulmonary oedema; Cerebral oedema; Renal failure chronic; Renal failure acute; Nephropathy; Nephritis | CN - NMPA | China |
| UB581 | Losartan Potassium Tablets | 25mg; 50mg; 100mg | Hypertension; Diabetic nephropathy | US - FDA | United States |
| UB579 | Mycophenolate Mofetil Tablets | 500mg | Renal transplant rejection prophylaxis; Cardiac transplant rejection prophylaxis; Hepatic transplant rejection prophylaxis; Lupus nephritis | US - FDA | United States |
| UB578 | Mycophenolate Mofetil Capsules | 250mg | Transplant rejection prophylaxis; Lupus nephritis | US - FDA | United States |
| UB573 | Irbesartan Tablets | 75mg; 150mg; 300mg | Essential hypertension; Diabetic nephropathy | US - FDA | United States |
| UB569 | Dactinomycin for Injection | 500mcg | Nephroblastoma; Rhabdomyosarcoma; Ewing's sarcoma; Testicular cancer; Gestational trophoblastic disease; Sarcoma | US - FDA | United States |
| UB546 | Sodium Nitroprusside Injection | 2ml:50mg | Oedema; Hypertension; Acute kidney injury | CN - NMPA | China |
获取最新活动与法规动态洞察
直接发送到您的邮箱
在此获取行业洞察与 Unibest 动态
联系我们 →